|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date27 May 1983 |
评价氨磺必利注射液预防术后恶心呕吐的有效性和安全性的随机、双盲、安慰
剂平行对照、多中心临床试验。
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy and safety of amisulpride injection in preventing postoperative nausea and vomiting.
评价氨磺必利注射液预防术后恶心呕吐(PONV)的有效性和安全性。
[Translation] To evaluate the efficacy and safety of amisulpride injection in preventing postoperative nausea and vomiting (PONV).
评价吸入用盐酸氨溴索溶液改善(成人)下呼吸道感染疾病粘痰症状的 有效性和安全性的随机、双盲、安慰剂平行对照、多中心的临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical study to evaluate the efficacy and safety of inhaled ambroxol hydrochloride solution in improving the symptoms of mucus in lower respiratory tract infections (adults)
评价山西阳和医药技术有限公司研制的吸入用盐酸氨溴索溶液改善(成 人)下呼吸道感染疾病粘痰症状的有效性和安全性。
[Translation] To evaluate the efficacy and safety of ambroxol hydrochloride solution for inhalation developed by Shanxi Yanghe Pharmaceutical Technology Co., Ltd. in improving the symptoms of sputum in lower respiratory tract infections (adults).
100 Clinical Results associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shanxi Yanghe Pharmaceutical Technology Co., Ltd.